Adolescent boys and girls are disproportionately affected in the current HIV epidemic. Numerous sociobehavioral studies have addressed the indirect drivers surrounding this vulnerability—for example, socioeconomic, geographical locale, and all forms of violence. However, the direct factors that may influence infection, such as the anatomical and physiological maturation of the anogenital tracts of adolescents or the trauma and wound-healing processes of injured mucosal tissue, are understudied and represent a gap within the HIV prevention field. This article reviews the epidemiology of HIV infection and violence in adolescents and the available basic science knowledge attending this research area. More importantly, this review highlights the most critical gaps that need to be addressed to design preventive interventions that are safe and effective for this population, which is key to ending the HIV pandemic.
Get full access to this article
View all access options for this article.
References
1.
UNICEF: UNICEF Analysis of UNAIDS 2012 HIV and AIDS Estimates. New York, NY, 2013.
2.
UNAIDS: Report on the global AIDS epidemic. Available at http://www.unaids.org/en/resources/campaigns/globalreport2013/globalreport, 2013.
3.
Centers for Disease Control and Prevention, National Center for Injury Prevention and Control, Division of Violence Prevention: Towards a violence-free generation using science to fuel action and end violence against children. Available at www.cdc.gov/violenceprevention/vacs/index.html (2015), accessed August8, 2016.
4.
GrantJM, MottetLA, TanisJ, HarrisonJ, HermanJL, KeislingM: Injustice at Every Turn: A Report of the National Transgender Discrimination Survey. National Center for Transgender Equality, Washington, DC, 2011.
5.
UN Women, United Nations Entity for Gender Equality and the Empowerment of Women: Fast facts: Statistics on violence against women and girls. Available at www.endvawnow.org/en/articles/299-fast-facts-statistics-on-violence-against-women-and-girls-.html (2012), accessed August8, 2016.
6.
KlotJF, et al.: Greentree white paper: Sexual violence, genitoanal injury, and HIV: Priorities for research, policy, and practice. AIDS Res Hum Retroviruses, 2012; 28:1379–1388.
7.
KlotJF, WiraCR: Sexual violence and genital injury: The physiology of HIV transmission risk. Am J Reprod Immunol, 2013; 69Suppl 1:2–3.
8.
BlackMC,BK, BreidingMJ, et al.: The National Intimate Partner and Sexual Violence Survey (NISVS): 2010 Summary Report. National Center for Injury Prevention and Control, Centers for Disease Control and Prevention, Atlanta, GA, 2011.
9.
LyonME, et al.: Prevalence and correlates of violence exposure among HIV-infected adolescents. J Assoc Nurses AIDS Care, 2014; 25:S5–S14.
10.
MachtingerEL, WilsonTC, HabererJE, WeissDS: Psychological trauma and PTSD in HIV-positive women: A meta-analysis. AIDS Behav, 2012; 16:2091–2100.
11.
SethP, DiClementeRJ, LovvornAE: State of the evidence: Intimate partner violence and HIV/STI risk among adolescents. Curr HIV Res, 2013; 11:528–535.
12.
NasrullahM, OrakaE, ChavezPR, ValverdeE, DinennoE: Nonvolitional sex and HIV-related sexual risk behaviours among MSM in the United States. AIDS, 2015; 29:1673–1680.
13.
FinneranC, StephensonR: Intimate partner violence among men who have sex with men: A systematic review. Trauma Violence Abuse, 2013; 14:168–185.
14.
LiY, et al.: Intimate partner violence and HIV infection among women: A systematic review and meta-analysis. J Int AIDS Soc, 2014; 17:18845.
15.
SperoffL. Clinical Gynecologic Endocrinology and Infertility, 8th ed. Lippincott, Williams and Wilcox, Philadelphia, PA, 2010.
16.
WiraCR, Rodriguez-GarciaM, PatelMV: The role of sex hormones in immune protection of the female reproductive tract. Nat Rev Immunol, 2015; 15:217–230.
17.
HickeyRJ, et al.: Vaginal microbiota of adolescent girls prior to the onset of menarche resemble those of reproductive-age women. mBio, 2015; 6:e00097-15.
18.
NarimatsuR, WoldayD, PattersonBK: IL-8 increases transmission of HIV Type 1 in cervical explant tissue. AIDS Res Hum Retroviruses, 2005; 21:228–233.
19.
AnahtarMN, et al.: Cervicovaginal bacteria are a major modulator of host inflammatory responses in the female genital tract. Immunity, 2015; 42:965–976.
20.
BahetiG, KingJR, AcostaEP, FletcherCV: Age-related differences in plasma and intracellular tenofovir concentrations in HIV-1-infected children, adolescents and adults. AIDS, 2013; 27:221–225.
21.
Richardson-HarmanN, et al: Multisite comparison of anti-human immunodeficiency virus microbicide activity in explant assays using a novel endpoint analysis. J Clin Microbiol, 2009; 47:3530–3539.
22.
KordyKN, BrysonY, DevilleJ, LiuZ, ElliotJ, Richardson-HarmanN, GrujicS, AntonP: Relationship of Tenofovir with HIV-1 suppression and an ex vivo model of biopsy infectability in adolescents. World Society for Pediatric Infectious Disease. 2015 (Rio de Janeiro).
23.
AgansR, et al.: Distal gut microbiota of adolescent children is different from that of adults. FEMS Microbiol Ecol, 2011; 77:404–412.
24.
StiehDJ, et al.: Vaginal challenge with an SIV-based dual reporter system reveals that infection can occur throughout the upper and lower female reproductive tract. PLoS Pathog, 2014; 10:e1004440.
25.
JonesJS, RossmanL, WynnBN, DunnuckC, SchwartzN: Comparative analysis of adult versus adolescent sexual assault: Epidemiology and patterns of anogenital injury. Acad Emerg Med, 2003; 10:872–877.
26.
Rodriguez-GarciaM, BarrFD, CristSG, FaheyJV, WiraCR: Phenotype and susceptibility to HIV infection of CD4+ Th17 cells in the human female reproductive tract. Mucosal Immunol, 2014; 7:1375–1385.
27.
WiraCR, FaheyJV: A new strategy to understand how HIV infects women: Identification of a window of vulnerability during the menstrual cycle. AIDS, 2008; 22:1909–1917.
28.
SodoraDL, GettieA, MillerCJ, MarxPA: Vaginal transmission of SIV: Assessing infectivity and hormonal influences in macaques inoculated with cell-free and cell-associated viral stocks. AIDS Res Hum Retroviruses, 1998; 14Suppl 1:S119–S123.
29.
VishwanathanSA, et al.: High susceptibility to repeated, low-dose, vaginal SHIV exposure late in the luteal phase of the menstrual cycle of pigtail macaques. J Acquir Immune Defic Syndr, 2011; 57:261–264.
30.
SabaE, et al.: Productive HIV-1 infection of human cervical tissue ex vivo is associated with the secretory phase of the menstrual cycle. Mucosal Immunol, 2013; 6:1081–1090.
31.
SmithSM, et al.: Topical estrogen protects against SIV vaginal transmission without evidence of systemic effect. AIDS, 2004; 18:1637–1643.
32.
ShenZ, et al.: Sex hormones regulate tenofovir-diphosphate in female reproductive tract cells in culture. PLoS One, 2014; 9:e100863.
33.
ShenZ, et al.: Estradiol regulation of nucleotidases in female reproductive tract epithelial cells and fibroblasts. PLoS One, 2013; 8:e69854.
34.
RamjeeG, McCormackS: The role of progestins in HIV acquisition in young women. Lancet Infect Dis, 2016; 16:389–390.
35.
Rodriguez-GarciaM, et al.: Estradiol reduces susceptibility of CD4+ T cells and macrophages to HIV-infection. PLoS One, 2013; 8:e62069.
36.
HellhammerDH, WüstS, KudielkaBM: Salivary cortisol as a biomarker in stress research. Psychoneuroendocrinology, 2009; 34:163–171.
37.
HornorGA: Normal ano-genital exam: Sexual abuse or not?. J Pediatr Health Care, 2010; 24:145–151.
38.
SommersMS, et al.: Health disparities in the forensic sexual assault examination related to skin color. J Forensic Nurs, 2009; 5:191–200.
39.
BakerRB, SommersMS: Relationship of genital injuries and age in adolescent and young adult rape survivors. J Obstet Gynecol Neonatal Nurs, 2008; 37:282–289.
40.
BrawnerBM, et al.: Exploring genitoanal injury and HIV risk among women: Menstrual phase, hormonal birth control, and injury frequency and prevalence. J Acquir Immune Defic Syndr, 2016; 71:207–212.
41.
BaggaleyRF, WhiteRG, BoilyM-C: HIV transmission risk through anal intercourse: Systematic review, meta-analysis and implications for HIV prevention. Int J Epidemiol, 2010; 39:1048–1063.
42.
HildenM, ScheiB, SideniusK: Genitoanal injury in adult female victims of sexual assault. Forensic Sci Int, 2005; 154:200–205.
FuchsEJ, et al.: Hyperosmolar sexual lubricant causes epithelial damage in the distal colon: Potential implication for HIV transmission. J Infect Dis, 2007; 195:703–710.
45.
BerensonAB, et al.: A case-control study of anatomic changes resulting from sexual abuse. Am J Obstet Gynecol, 2000; 182:820–831; discussion 831–824.
46.
FinkelMA: Child sexual abuse: A physician's introduction to historical and medical validation. J Am Osteopath Assoc, 1989; 89:1143–1149.
47.
KelloggND, MenardSW, SantosA: Genital anatomy in pregnant adolescents: “Normal” does not mean “nothing happened.” Pediatrics, 2004; 113:e67–e69.
48.
McCannJ, MiyamotoS, BoyleC, RogersK: Healing of hymenal injuries in prepubertal and adolescent girls: A descriptive study. Pediatrics, 2007; 119:e1094–e1106.
49.
EngelandCG, SabzeheiB, MaruchaPT: Sex hormones and mucosal wound healing. Brain Behav Immun, 2009; 23:629–635.
50.
EngelandCG, BoschJA, CacioppoJT, MaruchaPT: Mucosal wound healing: The roles of age and sex. Arch Surg, 2006; 141:1193–1197.
51.
SweeneyYTC, AngelesRO, CummingsPK, SmithD, PattonDL: Pigtailed macaque model refinement: Topical microbicide safety in the presence of coitus. J Med Primatol, 2011; 40:327–334.
52.
VincentKL, et al.: High resolution imaging of epithelial injury in the sheep cervicovaginal tract: A promising model for testing safety of candidate microbicides. Sex Transm Dis, 2009; 36:312–318.
